The study uncovers a novel immune evasion strategy employed by DENV that involves N207-linked glycans on NS1 and identifies the PD-L1/PD-1 axis as a previously unrecognized mechanism of dengue immunopathogenesis, which may inform future therapeutic strategies. Here, CD274 is linked to dengue disease.